Arroyo V, Moreau R, Jalan R. Acute-on-chronic liver failure. N Engl J Med. 2020;382(22):2137–45. https://doi.org/10.1056/NEJMra1914900.

Article  CAS  PubMed  Google Scholar 

Valantine B, Sundaray N, Mishra D, Sahu S, Narayan J, Panda N, B, et al. Predictors of early mortality among patients with acute-on-chronic liver failure. JGH Open. 2021;5(6):686–94. https://doi.org/10.1002/jgh3.12557.

Article  PubMed  PubMed Central  Google Scholar 

Chen JF, Weng WZ, Huang M, Peng XH, He JR, Zhang J, et al. Derivation and validation of a nomogram for predicting 90 day survival in patients with HBV-related acute-on-chronic liver failure. Front Med. 2021;8: 692669. https://doi.org/10.3389/fmed.2021.692669.

Article  Google Scholar 

Chen B, Lin S. Albumin-bilirubin (ALBI) score at admission predicts possible outcomes in patients with acute-on-chronic liver failure. Medicine. 2017;96(24): e7142. https://doi.org/10.1097/MD.0000000000007142.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao RH, Shi Y, Zhao H, Wu W, Sheng JF. Acute-on-chronic liver failure in chronic hepatitis B: an update. Exp Rev Gastroenterol Hepatol. 2018;12(4):341–50. https://doi.org/10.1080/17474124.2018.1426459.

Article  CAS  Google Scholar 

Hou Y, Zhang Q, Gao F, Mao DW, Li J, Gong ZJ, et al. Artificial neural network-based models used for predicting 28 and 90 day mortality of patients with hepatitis B-associated acute-on-chronic liver failure. BMC Gastroenterol. 2020;20(1):75. https://doi.org/10.1186/s12876-020-01191-5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao R, Li Y, Cao Y, Zheng RJ, Tang L, Yang JZ, et al. Glucocorticoid versus traditional therapy for hepatitis B virus–related acute-on-chronic liver failure: a systematic review and meta-analysis. Medicine. 2020;99(25): e20604. https://doi.org/10.1097/MD.0000000000020604.

Article  PubMed  PubMed Central  Google Scholar 

Kim TY, Song DS, Kim HY, Sinn DH, Yoon EL, Kim CW, et al. Characteristics and discrepancies in acute-on-chronic liver failure: need for a unified definition. PLoS One. 2016;11(1): e0146745. https://doi.org/10.1371/journal.pone.0146745.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moreau R, Gao B, Papp M, Bañares R, Kamath PS. Acute-on-chronic liver failure: a distinct clinical syndrome. J Hepatol. 2021;75(Suppl 1):S27-s35. https://doi.org/10.1016/j.jhep.2020.11.047.

Article  PubMed  Google Scholar 

Yu Z, Zhang Y, Cao Y, Xu MM, You SL, Chen Y, et al. A dynamic prediction model for prognosis of acute-on-chronic liver failure based on the trend of clinical indicators. Sci Rep. 2021;11(1):1810. https://doi.org/10.1038/s41598-021-81431-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pereira G, Baldin C, Piedade J, Reis V, Valdeolivas T, Victor L, et al. Combination and sequential evaluation of acute-on-chronic liver failure (ACLF) and hyponatremia and prognosis in cirrhotic patients. Dig Liver Dis. 2020;52(1):91–7. https://doi.org/10.1016/j.dld.2019.08.013.

Article  CAS  PubMed  Google Scholar 

Choudhury A, Jindal A, Maiwall R, Sharma MK, Sharma BC, Pamecha V, et al. Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models. Hepatol Int. 2017;11(5):461–71. https://doi.org/10.1007/s12072-017-9816-z.

Article  CAS  PubMed  Google Scholar 

Gustot T, Fernandez J, Garcia E, Morando F, Caraceni P, Alessandria C, et al. Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis. Hepatology. 2015;62(1):243–52. https://doi.org/10.1002/hep.27849.

Article  PubMed  Google Scholar 

Iervasi G, Pingitore A, Landi P, Raciti M, Ripoli A, Scarlattini M, et al. Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation. 2003;107(5):708–13. https://doi.org/10.1161/01.CIR.0000048124.64204.3F.

Article  PubMed  Google Scholar 

Bunevicius A, Iervasi G, Bunevicius R. Neuroprotective actions of thyroid hormones and low T3 syndrome as a biomarker in acute cerebrovascular disorders. Expert Rev Neurother. 2015;15(3):315–26. https://doi.org/10.1586/14737175.2015.1013465.

Article  CAS  PubMed  Google Scholar 

Fan J, Yan P, Wang Y, Shen B, Ding F, Liu Y. Prevalence and clinical significance of low T3 syndrome in non-dialysis patients with chronic kidney disease. Med Sci Monitor. 2016;22:1171–9. https://doi.org/10.12659/MSM.895953.

Article  CAS  Google Scholar 

Ta A, Koklu S, Beyazit Y, Kert M, Sayilir A, Yesil Y, et al. Thyroid hormone levels predict mortality in intensive care patients with cirrhosis. Am J Med Sci. 2012;344(3):175–9. https://doi.org/10.1097/MAJ.0b013e318239a666.

Article  Google Scholar 

Wang X, Mao J, Zhou X, Li Q, Gao L, Zhao J. Thyroid stimulating hormone triggers hepatic mitochondrial stress through cyclophilin D acetylation. Oxid Med Cell Longev. 2020;2020:1–12.

Article  Google Scholar 

Wu D, Sun Z, Liu X, Rao Q, Chen W, Wang J, et al. HINT: a novel prognostic model for patients with hepatitis B virus–related acute-on-chronic liver failure. Aliment Pharmacol Ther. 2018;48(7):1426–37. https://doi.org/10.1111/apt.14927.

Article  CAS  Google Scholar 

Wu Y, You S, Zang H, Liu H, Mao Y, Mao P, et al. Usefulness of serum thyroid-stimulation hormone (TSH) as a prognostic indicator for acute-on-Chronic liver failure. Ann Hepatol. 2015;14(2):218–24. https://doi.org/10.1016/S1665-2681(19)30784-7.

Article  CAS  PubMed  Google Scholar 

Liver Failure and Artificial Liver Group of Infectious Diseases Branch of Chinese Medical Association. Severe Liver Disease and Artificial Liver Group of Chinese Hepatology Branch of Chinese Medical Association. Guidelines for the diagnosis and treatment of liver failure (2018 edition). Chin J Clin Infect Dis. 2018;11(6):401–10.

Google Scholar 

Chinese Society of Infectious Diseases, Chinese Medical Association Chinese Society of Hepatology, Chinese Medical Association. The guidelines of prevention and treatment for chronic hepatitis B (2019 version). J Pract Hepatol. 2020. https://doi.org/10.3969/j.issn.1672-5069.2020.01.044.

Article  Google Scholar 

Qiao S, Zhang SC, Zhang RR, et al. Thyroid function and low free triiodothyronine in Chinese patients with autoimmune encephalitis. Front Immunol. 2022;13: 821746. https://doi.org/10.3389/fimmu.2022.821746.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lau T, Ahmad J. Clinical applications of the model for end-stage liver disease (MELD) in hepatic medicine. Hepat Med. 2013;2013(5):1–10. https://doi.org/10.2147/HMER.S9049.eCollection.

Article  Google Scholar 

Zhou C, Zhang N, He TT, Wang Y, Wang LF, Sun YQ, et al. High levels of serum interleukin-6 increase mortality of hepatitis B virus-associated acute-on-chronic liver failure. World J Gastroenterol. 2020;26(30):4479–88. https://doi.org/10.3748/wjg.v26.i30.4479.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu YY, Ayers S, Milanesi A, Teng XC, Rabi S, Akiba Y, et al. Thyroid hormone receptor sumoylation is required for preadipocyte differentiation and proliferation. J Biol Chem. 2015;290(12):7402–15. https://doi.org/10.1074/jbc.M114.600312.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Van Den Berg EH, Van Tienhoven-Wind LJ, Amini M, Schreuder TCMA, Faber KN, Blokzijl H, et al. Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the lifelines cohort study. Metabolism. 2017;67:62–71. https://doi.org/10.1016/j.metabol.2016.11.002.

Article  CAS  PubMed  Google Scholar 

Su W, Zhao XQ, Wang M, Chen H, Li HW. Low T3 syndrome improves risk prediction of in-hospital cardiovascular death in patients with acute myocardial infarction. J Cardiol. 2018;72(3):215–9. https://doi.org/10.1016/j.jjcc.2018.02.013.

Article  PubMed  Google Scholar 

Agiasotelli D, Alexopoulou A, Vasilieva L, Dourakis SP. Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure. J Hepatol. 2014;61(6):1446–7. https://doi.org/10.1016/j.jhep.2014.06.042.

Article  PubMed  Google Scholar 

Singal AK, Kamath PS. Acute on chronic liver failure in non-alcoholic fatty liver and alcohol associated liver disease. Transl Gastroenterol Hepatol. 2019;4:74. https://doi.org/10.21037/tgh.2019.09.11.

Article  PubMed  PubMed Central  Google Scholar 

Floreani A, Mangini C, Reig A, Franceschet I, Cazzagon N, Perini L, et al. Thyroid dysfunction in primary biliary cholangitis: a comparative study at two European centers. Am J Gastroenterol. 2017;112(1):114–9. https://doi.org/10.1038/ajg.2016.479.

Article  PubMed  Google Scholar 

Yang B, Wu YK, Chen ZC, Gao ZL, Chong YT, Xie SB. The dynamic changes of AST, ALT, TBil and PT and their relationship with prognosis of acute-on-chronic hepatitis B liver failure. J Clin Hepatol. 2012. https://doi.org/10.3969/j.issn.1001-5256.2012.03.012.

Article  Google Scholar 

Qiang L, Qin J, Sun C, Sheng YJ, Chen W, Qiu BD, et al. A novel predictive model based on inflammatory markers to assess the prognosis of patients with HBV-related acute-on-chronic liver failure: a retrospective cohort study. BMC Gastroenterol. 2020;20(1):301. https://doi.org/10.1186/s12876-020-01437-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bannaga A, Arasaradnam RP. Neutrophil to lymphocyte ratio and albumin bilirubin grade in hepatocellular carcinoma: a systematic review. World J Gastroenterol. 2020;26(33):5022–49. https://doi.org/10.3748/wjg.v26.i33.5022.

Article  CAS  PubMed